» Articles » PMID: 24136034

Intraocular Pressure Control with Ahmed Glaucoma Drainage Device in Patients with Cicatricial Ocular Surface Disease-associated or Aniridia-related Glaucoma

Overview
Journal Int Ophthalmol
Specialty Ophthalmology
Date 2013 Oct 19
PMID 24136034
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

To analyze the control of intraocular pressure (IOP) with an Ahmed glaucoma drainage device (AGDD) in two groups of glaucoma patients--one with cicatricial ocular surface disease (COSD) and one with aniridia. This is a retrospective comparative case series of nine patients (11 eyes) with COSD and six patients (8 eyes) with aniridia who underwent AGDD surgery to control IOP. The main outcome measure in both groups was stability of IOP between 6 and 21 mmHg. Mean IOP decreased significantly in both groups after AGDD surgery (29.6 ± 8.7 vs 14.7 ± 2.5, p = 0.008 in the COSD group; 26.3 ± 8.2 vs 15.3 ± 5.8, p = 0.008 in the aniridia group). Over a mean post-surgery follow-up of 37.1 months in the COSD group, we managed to control IOP in nine eyes; IOP control was successful in 87 % of eyes at 12 months and 58 % of eyes at 26 months. Over a mean post-surgery follow-up of 37.4 months in the aniridia group, we managed to control the IOP in seven eyes; IOP control was successful in 87 % of eyes at 12 months. AGDD surgery had no significant deleterious effect on visual acuity in either group. A severe complication occurred in one eye (1/8) in the aniridia group (lost vision due to retinal detachment) and in one eye (1/11) in the COSD group (tube exposure). AGDD surgery is effective in controlling IOP and has a low complication rate in COSD and aniridia patients; however, some of the complications are severe and prompt management is needed to prevent deleterious results.

Citing Articles

Outcome of illuminated microcatheter-assisted circumferential trabeculotomy following failed angle surgery in PAX6 aniridic glaucoma: a case report and literature review.

Wu T, Cui C, Li Y, Hong Y, Zhang C BMC Ophthalmol. 2024; 24(1):157.

PMID: 38594720 PMC: 11005255. DOI: 10.1186/s12886-024-03425-6.


Long-Term Clinical Outcomes of Ahmed Valve Implantation in Aniridic Glaucoma.

Bolek B, Wylegala E, Tarnawska D Biomedicines. 2023; 11(11).

PMID: 38001995 PMC: 10669343. DOI: 10.3390/biomedicines11112996.


Congenital aniridia beyond black eyes: From phenotype and novel genetic mechanisms to innovative therapeutic approaches.

Daruich A, Duncan M, Robert M, Lagali N, Semina E, Aberdam D Prog Retin Eye Res. 2022; 95:101133.

PMID: 36280537 PMC: 11062406. DOI: 10.1016/j.preteyeres.2022.101133.


Clinical outcomes and visual prognostic factors in congenital aniridia.

Jacobson A, Mian S, Bohnsack B BMC Ophthalmol. 2022; 22(1):235.

PMID: 35614435 PMC: 9131660. DOI: 10.1186/s12886-022-02460-5.


Improving long-term intraocular pressure and visual outcomes in eyes with aniridic glaucoma.

Sihota R, Selvan H, Azmira K, Dada T, Sharma A, Gupta A Graefes Arch Clin Exp Ophthalmol. 2021; 259(12):3749-3755.

PMID: 34328551 DOI: 10.1007/s00417-021-05335-5.


References
1.
Al-Torbak A . Graft survival and glaucoma outcome after simultaneous penetrating keratoplasty and ahmed glaucoma valve implant. Cornea. 2003; 22(3):194-7. DOI: 10.1097/00003226-200304000-00002. View

2.
Nelson L, Spaeth G, Nowinski T, Margo C, Jackson L . Aniridia. A review. Surv Ophthalmol. 1984; 28(6):621-42. DOI: 10.1016/0039-6257(84)90184-x. View

3.
Rahi A, Chapman C, Garner A, Wright P . Pathology of practolol-induced ocular toxicity. Br J Ophthalmol. 1976; 60(5):312-23. PMC: 1042724. DOI: 10.1136/bjo.60.5.312. View

4.
Adachi M, Dickens C, Hetherington Jr J, Hoskins H, Iwach A, Wong P . Clinical experience of trabeculotomy for the surgical treatment of aniridic glaucoma. Ophthalmology. 1997; 104(12):2121-5. DOI: 10.1016/s0161-6420(97)30041-4. View

5.
Tauber J, Melamed S, Foster C . Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology. 1989; 96(1):33-7. DOI: 10.1016/s0161-6420(89)32942-3. View